274 related articles for article (PubMed ID: 17874717)
21. Botulinum toxin treatment in cerebral palsy: evidence for a new treatment option.
Kirschner J; Berweck S; Mall V; Korinthenberg R; Heinen F
J Neurol; 2001 Apr; 248 Suppl 1():28-30. PubMed ID: 11357236
[TBL] [Abstract][Full Text] [Related]
22. The effect of botulinum toxin A (Botox) injections used to treat limb spasticity on speech patterns in children with dysarthria and cerebral palsy: A report of two cases.
Workinger MS; Kent RD; Meilahn JR
J Pediatr Rehabil Med; 2017 May; 10(2):137-143. PubMed ID: 28582880
[TBL] [Abstract][Full Text] [Related]
23. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.
Koman LA; Paterson Smith B; Balkrishnan R
Paediatr Drugs; 2003; 5(1):11-23. PubMed ID: 12513103
[TBL] [Abstract][Full Text] [Related]
24. Botulinum toxin type A injection increases range of motion in hip, knee and ankle joint contractures of children with cerebral palsy.
Aktaş E; Ömeroğlu H
Eklem Hastalik Cerrahisi; 2019 Aug; 30(2):155-62. PubMed ID: 31291865
[TBL] [Abstract][Full Text] [Related]
25. Parameters for predicting favorable responses to botulinum toxin in children with cerebral palsy.
Fattal-Valevski A; Giladi N; Domanievitz D; Zuk L; Masterman R; Harel S; Wientroub S; Hayek S
J Child Neurol; 2002 Apr; 17(4):272-7. PubMed ID: 12088083
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of Multilevel Botulinum Toxin A Injection with Integrated Treatment Program on Spasticity Reduction in Non-Ambulatory Young Children with Cerebral Palsy.
Aydil S; Akpinar FM; Akpinar E; Beng K; Yagmurlu MF
Med Princ Pract; 2019; 28(4):309-314. PubMed ID: 30840957
[TBL] [Abstract][Full Text] [Related]
27. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
[TBL] [Abstract][Full Text] [Related]
28. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
Kaishou Xu ; Tiebin Yan ; Jianning Mai
Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
[TBL] [Abstract][Full Text] [Related]
29. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
Lundy CT; Doherty GM; Fairhurst CB
Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
[TBL] [Abstract][Full Text] [Related]
30. Effects of botulinum toxin serotype A on sleep problems in children with cerebral palsy and on mothers sleep quality and depression.
Binay Safer V; Ozbudak Demir S; Ozkan E; Demircioglu Guneri F
Neurosciences (Riyadh); 2016 Oct; 21(4):331-337. PubMed ID: 27744462
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
Madsen ES; Sonne-Holm S; Wong C; Curtis D; Bencke J
Ugeskr Laeger; 2015 Jan; 177(3):V07140409. PubMed ID: 25613095
[TBL] [Abstract][Full Text] [Related]
32. The influence of physical therapy and anti-botulinum toxin antibody on the efficacy of botulinum toxin-A injections in children with spastic cerebral palsy.
Jang DH; Sung IY
Dev Neurorehabil; 2014 Dec; 17(6):414-9. PubMed ID: 25372070
[TBL] [Abstract][Full Text] [Related]
33. [Effectiveness of botulinum toxin in diminishing lower limbs spasticity in children with diplegic form of cerebral palsy].
Gugała B; Snela S
Chir Narzadow Ruchu Ortop Pol; 2011; 76(2):91-5. PubMed ID: 21853909
[TBL] [Abstract][Full Text] [Related]
34. Development of a framework to define the functional goals and outcomes of botulinum toxin A spasticity treatment relevant to the child and family living with cerebral palsy using the International Classification of Functioning, Disability and Health for Children and Youth.
Preston N; Clarke M; Bhakta B
J Rehabil Med; 2011 Nov; 43(11):1010-5. PubMed ID: 22031347
[TBL] [Abstract][Full Text] [Related]
35. Treatment with Botulinum toxin A in a total population of children with cerebral palsy - a retrospective cohort registry study.
Franzén M; Hägglund G; Alriksson-Schmidt A
BMC Musculoskelet Disord; 2017 Dec; 18(1):520. PubMed ID: 29228927
[TBL] [Abstract][Full Text] [Related]
36. Effects of different dilutions of botulinum toxin type A treatment for children with cerebral palsy with spastic ankle plantarflexor: a randomized controlled trial.
Lee JH; Sung IY; Yoo JY; Park EH; Park SR
J Rehabil Med; 2009 Sep; 41(9):740-5. PubMed ID: 19774308
[TBL] [Abstract][Full Text] [Related]
37. Treating spastic equinus foot from cerebral palsy with botulinum toxin type A: what factors influence the results?: an analysis of 189 consecutive cases.
Pascual-Pascual SI; Pascual-Castroviejo I; Ruiz PJ
Am J Phys Med Rehabil; 2011 Jul; 90(7):554-63. PubMed ID: 21765274
[TBL] [Abstract][Full Text] [Related]
38. Is an instrumented spasticity assessment an improvement over clinical spasticity scales in assessing and predicting the response to integrated botulinum toxin type a treatment in children with cerebral palsy?
Bar-On L; Van Campenhout A; Desloovere K; Aertbeliën E; Huenaerts C; Vandendoorent B; Nieuwenhuys A; Molenaers G
Arch Phys Med Rehabil; 2014 Mar; 95(3):515-23. PubMed ID: 23994052
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of a program of application of the botulinum toxin type A in children with cerebral palsy in Vale do Jequitinhonha].
Silva GF; Teles MC; Santos SA; Ferreira FO; Almeida KM; Camargos AC
Cien Saude Colet; 2013 Jul; 18(7):2075-84. PubMed ID: 23827912
[TBL] [Abstract][Full Text] [Related]
40. The effect of spasticity on cortical somatosensory-evoked potentials: changes of cortical somatosensory-evoked potentials after botulinum toxin type A injection.
Park ES; Park CI; Kim DY; Kim YR
Arch Phys Med Rehabil; 2002 Nov; 83(11):1592-6. PubMed ID: 12422331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
